X4 Pharmaceuticals, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 11, 2025, reports on the results of the Annual Meeting of Stockholders held on June 9, 2025. The filing details the voting outcomes for three proposals submitted to shareholders. As of the record date of April 15, 2025, there were 173,662,376 shares of common stock outstanding. All vote counts are presented on a pre-reverse stock split basis, preceding the 1-for-30 reverse stock split effective April 28, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal 1 - Election of Directors: R. Keith Woods was elected as a director to serve until the 2028 Annual Meeting.
- For: 52,191,014
- Withheld: 29,872,082
- Broker Non-Votes: 53,811,292
- Proposal 2 - Ratification of Independent Auditor: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- For: 128,889,553
- Against: 6,595,740
- Abstain: 389,095
- Proposal 3 - Say-On-Pay: Stockholders approved the non-binding advisory vote on Named Executive Officer compensation.
- For: 67,793,970
- Against: 12,234,847
- Abstain: 2,034,279
- Broker Non-Votes: 53,811,292
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the impact of the 1-for-30 reverse stock split (effective April 28, 2025) on current share counts and voting power, as reported figures are pre-split.
- Confirm the tenure of the newly elected director, R. Keith Woods, through the 2028 Annual Meeting.
- Review the definitive proxy statement filed on April 25, 2025, for detailed compensation data referenced in the Say-On-Pay vote.
- Note the significant number of broker non-votes (53,811,292) in the director election and Say-On-Pay proposals.